Papillon-Lefevre syndrome treated by acitretin: case report and cytokine profile.
Details
Request a copy Under indefinite embargo.
UNIL restricted access
State: Public
Version: Final published version
License: Not specified
UNIL restricted access
State: Public
Version: Final published version
License: Not specified
Serval ID
serval:BIB_A3461686B46A
Type
Article: article from journal or magazin.
Publication sub-type
Case report (case report): feedback on an observation with a short commentary.
Collection
Publications
Institution
Title
Papillon-Lefevre syndrome treated by acitretin: case report and cytokine profile.
Journal
Journal of the European Academy of Dermatology and Venereology
ISSN
1468-3083 (Electronic)
ISSN-L
0926-9959
Publication state
Published
Issued date
03/2022
Peer-reviewed
Oui
Volume
36
Number
3
Pages
e235-e238
Language
english
Notes
Publication types: Case Reports ; Letter
Publication Status: ppublish
Publication Status: ppublish
Abstract
Papillon-Lefevre Syndrome (PLS) is (OMIM 245'000) a rare genodermatosis, transmitted in an autosomal recessive mode. The disease results from mutations in the CTSC gene (11q14.2) encoding cathepsin C or dipeptidyl peptidase <sup>1</sup> . The clinic is marked by recurrent gingivitis, tooth loss and palmoplantar hyperkeratosis. We report the case of a 19-year-old patient who presented with palmoplantar hyperkeratosis and erythemato-squamous plaques (figure 1), with involvement of knees and elbows. The patient had recurrent abscesses mainly on inguinal and axillary areas.
Keywords
Acitretin/therapeutic use, Cytokines, Humans, Keratolytic Agents/therapeutic use, Papillon-Lefevre Disease
Pubmed
Web of science
Create date
06/11/2021 16:32
Last modification date
05/08/2022 5:37